BUJUMBURA March 1st (ABP) – The Association of Kenyans Living in Burundi (AKB) held a press conference on Wednesday February 28, 2018 in Bujumbura to launch an appeal for help to child Chadrack Dusenge, a native of Rugombo commune in Cibitoke province for the check up and treatment of cancer in Kenya.
AKB chairman Bernard Teigutwo said that after the first treatment in Nairobi, Kenya in October 2017, the 11-year-old child is in need of surgery for non-Hodgkin Lymphoma, a cancer of high aggressiveness attacking lymphocytes or white blood cells, at Kenyata National Hospital in Kenya.
According to Teigutwo, the Doctors recommended that surgery be done in collaboration with surgeons from the United States of America.
After the final diagnosis, the doctors found that Chadrack Dusenge was suffering from highly aggressive non-Hodgkin lymphoma cancer, with a high risk of surgery for such a large tumor; This prompted physicians to recommend the immediate start of chemotherapy treatment prior to surgery to minimize the spread of cancer.
Mr. Teigutwo said that the first fundraising campaign organized by Kenyan natives living in Burundi raised $ 1,600 in one week, a sum that allowed Chadrack dusenge and his guardian to travel for the first time to Kenya on October 9, 2017, for treatment. He added that according to a weekly treatment that Dusenge has undergone chemotherapy since November 3, 2017 to mid-January 2018, the results are very encouraging.
In order to cover all the expenses related to the case of Chadrack Dusenge, said Mr. Tuegutwo, an amount of $ 17,000 is needed. This will help the child continue chemotherapy treatments, pay hospital bills since November 2017, accommodation and logistics for the next four months and his check up. The money will also help pay the monthly round-trip travel costs of his caretaker between Burundi and Kenya and other expenses that may arise, he added. The AKB chairman makes a strong appeal to anyone who can, to intervene to see how to help this boy in an emergency way.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *